JP Morgan Maintains Neutral on ArcBest, Raises Price Target to $81
Benzinga Newsdesk 9 months ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Brian Ossenbeck maintains ArcBest (NASDAQ:ARCB) with a Neutral and raises the price target from $76 to $81.
JP Morgan analyst Brian Ossenbeck maintains ArcBest (NASDAQ:ARCB) with a Neutral and raises the price target from $76 to $81.